查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1529804

稀有細胞隔離市場規模、佔有率、趨勢分析報告：按產品類型、細胞類型、技術、地區和細分市場預測，2024-2030 年

Rare Cell Isolation Market Size, Share & Trends Analysis Report By Product (Reagents & Kits, Instrument), By Cell Type (Circulating Tumor Cells, Stem Cells), By Technology, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

稀有細胞分離市場的成長與趨勢：

根據Grand View Research, Inc.最新報告，預計2030年全球稀有細胞分離市場規模將達34.6億美元，2024年至2030年複合年成長率為9.71%。

這是由持續的技術進步、慢性病盛行率的增加、對個人化醫療的需求不斷成長以及癌症研究的進步所推動的。此外，稀有幹細胞的分離對於再生醫學和幹細胞治療至關重要，從而推動了預測期內的需求。

COVID-19 大流行加速了診斷和治療研究的進展，對市場產生了積極影響。了解病毒和開發有效治療方法的迫切需求促使人們對尖端細胞分離技術進行投資，以促進稀有免疫細胞和循環病毒顆粒的快速分離和分析。因此，不斷成長的需求將推動整個生物技術產業的創新和合作，從而增強單細胞分析、液態切片、個人化醫療的能力，並且在預測期內對稀有細胞分離的需求不斷增加。

慢性疾病，特別是癌症的盛行率不斷增加，顯著增加了對稀有細胞分離技術的需求。分離這些細胞可以進行早期診斷、監測治療效果並為個別患者開發標靶治療。透過捕捉和治療這些稀有細胞，研究人員和臨床醫生可以識別特定的基因突變，識別腫瘤行為，制定個人化的治療計劃，並最終改善患者的治療結果，有望改善腫瘤學領域並推動腫瘤學領域的發展。因此，對用於預測行為的稀有細胞的需求不斷成長預計將推動預測期內的市場成長。

然而，微射流和流式細胞技術等先進的稀有細胞分離技術通常需要大量投資。昂貴的設備、試劑和維護成本讓許多研究機構和臨床實驗室望而卻步，限制了市場的擴張。此外，分離稀有細胞的過程在技術上很複雜，需要專門的知識和訓練。這種複雜性預計將成為採用的障礙並進一步阻礙市場成長。

稀有細胞隔離市場報告亮點

  • 試劑和套件領域預計將在2023年佔據市場主導地位，並在2024年至2030年以最快的複合年成長率成長。與複雜且昂貴的細胞分離設備相比，試劑和套件的成本效益在其廣泛使用中發揮重要作用。
  • 2023年，幹細胞細分市場佔比最大，為39.46%。製藥和生物技術產業嚴重依賴分離的幹細胞來篩檢新藥、研究細胞反應並評估潛在治療方法的安全性。研究和工業領域的廣泛應用鞏固了該領域的主導地位。
  • 2023 年，基於微流體的技術領域佔據市場主導地位。微流體技術的不斷創新和進步有助於其在市場上的主導地位。研究人員和公司正在開發新的微流體設備和技術，以提供改進的性能、易用性以及與其他分析工具的整合。這些進步正在推動基於微流體的細胞分離的廣泛使用和擴大應用。
  • 由於癌症發病率上升、久坐的生活方式以及慢性病盛行率上升，北美將在 2023 年佔據市場主導地位。同時，亞太地區預計在預測期內將以最高的複合年成長率成長。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章稀有細胞分離市場的變數、趨勢和範圍

  • 市場體系展望
  • 市場動態
  • 稀有細胞分離市場分析工具

第 4 章 稀有細胞分離市場：依產品估算與趨勢分析

  • 細分儀表板
  • 全球稀有細胞分離市場：產品波動分析
  • 全球稀有細胞分離市場：規模和趨勢分析（按產品），2018-2030
  • 試劑和套件
  • 裝置

第5章稀有細胞分離市場：依細胞類型估算與趨勢分析

  • 細分儀表板
  • 全球稀有細胞分離市場：依細胞類型進行差異分析
  • 全球稀有細胞分離市場：規模和趨勢分析（按細胞類型），2018-2030
  • 循環性腫瘤細胞
  • 幹細胞
  • 胎兒細胞
  • 稀有免疫細胞
  • 循環內皮細胞
  • 其他稀有細胞類型

第6章稀有細胞分離市場：技術估算與趨勢分析

  • 細分儀表板
  • 全球稀有細胞分離市場：技術變遷分析
  • 全球稀有細胞分離市場：規模與趨勢分析（按技術），2018-2030
  • 微流體技術
  • 螢光活化細胞分選
  • 磁珠分離

第7章稀有細胞分離市場：區域估計與趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018-2030年市場規模、預測趨勢分析：
  • 北美洲
    • 2018-2030年北美市場估計與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018-2030年歐洲市場估計與預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030 年亞太市場估計與預測
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 2018-2030 年拉丁美洲市場估計與預測
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 2018年至2030年中東和非洲市場估計和預測
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 公司/競爭對手分類
  • 策略規劃
  • 2023 年企業市場分析
  • 公司簡介/上市公司
    • Miltenyi Biotec
    • Thermo Fisher Scientific, Inc.
    • Danaher
    • QIAGEN NV
    • Bio-techne
    • STEMCELL Technologies
    • CELLENION
    • RareCyte
    • Illumina, Inc.
    • Bio-Rad Laboratories, Inc.
Product Code: GVR-4-68040-359-9

Rare Cell Isolation Market Growth & Trends:

The global rare cell isolation market size is anticipated to reach USD 3.46 billion by 2030, registering a CAGR of 9.71% from 2024 to 2030, according to a new report by Grand View Research, Inc. This is attributed to the continuous technological advancements, increasing prevalence of chronic diseases, growing demand for personalized medicine, and advancements in cancer research. Furthermore, the isolation of rare stem cells is essential for regenerative medicine and stem cell therapy, thereby propelling the demand over the forecast period.

The COVID-19 pandemic has positively impacted the market by accelerating diagnostics and therapeutic research advancements. The urgent need to understand the virus and develop effective treatments has stimulated investment in cutting-edge cell isolation technologies, facilitating the rapid isolation and analysis of rare immune cells and circulating viral particles. Thus, the growing demand has driven innovation and collaboration across the biotech industry, resulting in enhanced single-cell analysis, liquid biopsy, and personalized medicine capabilities, boosting the demand for rare cell isolation over the forecast period.

The increasing prevalence of chronic diseases, especially cancer, has significantly increased the demand for rare cell isolation techniques. Isolation of these cells allows for early diagnosis, monitoring of treatment efficacy, and development of targeted therapies tailored to individual patients. By capturing and studying these rare cells, researchers and clinicians are anticipated to identify specific genetic mutations, recognize tumor behavior, and devise personalized treatment plans, ultimately improving patient outcomes and advancing the field of oncology. Thus, the growing demand for rare cells in predicting behavior is estimated to propel the market growth over the forecast period.

However, advanced rare cell isolation technologies, such as microfluidics and flow cytometry, often require significant investment. The high equipment, reagents, and maintenance costs can be prohibitive for many research institutions and clinical labs, limiting market expansion. In addition, the processes involved in rare cell isolation are technically complex, thus requiring specialized expertise and training. This complexity is anticipated to create a barrier to adoption, further hampering the market's growth.

Rare Cell Isolation Market Report Highlights:

  • The reagent & kits segment dominated the market in 2023 and is expected to grow at the fastest CAGR from 2024 to 2030. The cost-effectiveness of reagents and kits compared to more sophisticated and expensive equipment for cell isolation plays a significant role in their widespread adoption
  • The stem cell type segment held the largest share of 39.46% in 2023. The pharmaceutical and biotechnology industries rely heavily on isolated stem cells to screen for new drugs, study cellular responses, and assess the safety of potential treatments. This widespread application in research and industry underpins the segment dominance
  • The microfluidics-based techniques technology segment dominated the market in 2023. Continuous innovation & advancements in microfluidics technology contributed to its leading position in the market. Researchers and companies are developing new microfluidic devices and methods that offer improved performance, ease of use, and integration with other analytical tools. These advancements are driving widespread adoption and expanding the applications of microfluidics-based cell isolation
  • North America dominated the market in 2023 due to the growing cancer incidence, sedentary lifestyle, and rising prevalence of chronic diseases. On the other hand, Asia Pacific is anticipated to grow at the highest CAGR over the forecast period

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Products Segment
    • 1.2.2. Cell Type Segment
    • 1.2.3. Technology Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
    • 1.8.1. Total Market: CAGR Calculation
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Rare cell isolation market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of chronic and rare diseases
      • 3.2.1.2. Technological advancement and innovation in cell isolation
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Strict regulations and compliances for cell separation
  • 3.3. Rare Cell Isolation Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Rare Cell Isolation Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Rare Cell Isolation Market Products Movement Analysis
  • 4.3. Global Rare Cell Isolation Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Reagent & Kits
    • 4.4.1. Reagent & kits market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Instrument
    • 4.5.1. Instrument market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Rare Cell Isolation Market: Cell Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Rare Cell Isolation Market Application Movement Analysis
  • 5.3. Global Rare Cell Isolation Market Size & Trend Analysis, by cell type, 2018 to 2030 (USD Million)
  • 5.4. Circulating Tumor Cells
    • 5.4.1. Circulating tumor cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Stem Cells
    • 5.5.1. Stem cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Fetal Cells
    • 5.6.1. Fetal cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Rare Immune Cells
    • 5.7.1. Rare immune cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Circulating Endothelial Cells
    • 5.8.1. Circulating endothelial cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.9. Other Rare Cell Types
    • 5.9.1. Other rare cell types market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Rare cell isolation market: Technology Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Rare Cell Isolation Market Technology Movement Analysis
  • 6.3. Global Rare Cell Isolation Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
  • 6.4. Microfluidics-based Techniques
    • 6.4.1. Microfluidics-based techniques market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Fluorescence-activated Cell Sorting
    • 6.5.1. Fluorescence-activated cell sorting market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Magnetic Bead Separation
    • 6.6.1. Magnetic bead separation market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Rare cell isolation market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Competitive scenario
      • 7.4.2.3. Regulatory framework
      • 7.4.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Competitive scenario
      • 7.4.3.3. Regulatory framework
      • 7.4.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Competitive scenario
      • 7.4.4.3. Regulatory framework
      • 7.4.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory framework
      • 7.5.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Regulatory framework
      • 7.5.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Competitive scenario
      • 7.5.4.3. Regulatory framework
      • 7.5.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Competitive scenario
      • 7.5.5.3. Regulatory framework
      • 7.5.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Competitive scenario
      • 7.5.6.3. Regulatory framework
      • 7.5.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Competitive scenario
      • 7.5.7.3. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Competitive scenario
      • 7.5.8.3. Regulatory framework
      • 7.5.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key country dynamics
      • 7.5.9.2. Competitive scenario
      • 7.5.9.3. Regulatory framework
      • 7.5.9.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Regulatory framework
      • 7.6.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. Regulatory framework
      • 7.6.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. Regulatory framework
      • 7.6.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Competitive scenario
      • 7.6.7.3. Regulatory framework
      • 7.6.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Regulatory framework
      • 7.8.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Competitive scenario
      • 7.8.3.3. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Competitive scenario
      • 7.8.4.3. Regulatory framework
      • 7.8.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key country dynamics
      • 7.8.5.2. Competitive scenario
      • 7.8.5.3. Regulatory framework
      • 7.8.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2023
  • 8.4. Company Profiles/Listing
    • 8.4.1. Miltenyi Biotec
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Thermo Fisher Scientific, Inc.
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Danaher
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. QIAGEN N.V.
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Bio-techne
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. STEMCELL Technologies
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. CELLENION
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. RareCyte
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Illumina, Inc.
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Bio-Rad Laboratories, Inc.
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • 1. List of abbreviation
  • 2. Global rare cell isolation market, by region, 2018 - 2030 (USD Million)
  • 3. Global rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 4. Global rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 5. Global rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 6. North America rare cell isolation market, by country, 2018 - 2030 (USD Million)
  • 7. North America rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 8. North America rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 9. North America rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 10. U.S. rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 11. U.S. rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 12. U.S. rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 13. Canada rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 14. Canada rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 15. Canada rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 16. Mexico rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 17. Mexico rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 18. Mexico rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 19. Europe rare cell isolation market, by country, 2018 - 2030 (USD Million)
  • 20. Europe rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 21. Europe rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 22. Europe rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 23. UK rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 24. UK rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 25. UK rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 26. Germany rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 27. Germany rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 28. Germany rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 29. France rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 30. France rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 31. France rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 32. Italy rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 33. Italy rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 34. Italy rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 35. Spain rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 36. Spain rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 37. Spain rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 38. Denmark rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 39. Denmark rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 40. Denmark rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 41. Sweden rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 42. Sweden rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 43. Sweden rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 44. Norway rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 45. Norway rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 46. Norway rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 47. Asia Pacific rare cell isolation market, by country, 2018 - 2030 (USD Million)
  • 48. Asia Pacific rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 49. Asia Pacific rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 50. Asia Pacific rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 51. Japan rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 52. Japan rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 53. Japan rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 54. China rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 55. China rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 56. China rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 57. India rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 58. India rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 59. India rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 60. Australia rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 61. Australia rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 62. Australia rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 63. South Korea rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 64. South Korea rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 65. South Korea rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 66. Thailand rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 67. Thailand rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 68. Thailand rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 69. Latin America rare cell isolation market, by country, 2018 - 2030 (USD Million)
  • 70. Latin America rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 71. Latin America rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 72. Latin America rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 73. Brazil rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 74. Brazil rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 75. Brazil rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 76. Argentina rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 77. Argentina rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 78. Argentina rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 79. MEA rare cell isolation market, by country, 2018 - 2030 (USD Million)
  • 80. MEA rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 81. MEA rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 82. MEA rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 83. South Africa rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 84. South Africa rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 85. South Africa rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 86. Saudi Arabia rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 87. Saudi Arabia rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 88. Saudi Arabia rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 89. UAE rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 90. UAE rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 91. UAE rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 92. Kuwait rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 93. Kuwait rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 94. Kuwait rare cell isolation market, by technology, 2018 - 2030 (USD Million)

List of Figures

  • 1. Rare cell isolation market segmentation
  • 2. Data analysis models
  • 3. Market formulation and validation
  • 4. Data validating & publishing
  • 5. Market research process
  • 6. Information procurement
  • 7. Primary research
  • 8. Value-chain-based sizing & forecasting
  • 9. QFD modelling for market share assessment
  • 10. Market formulation & validation
  • 11. Commodity flow analysis
  • 12. Market outlook
  • 13. Segment snapshot-1
  • 14. Segment snapshot-2
  • 15. Competitive landscape snapshot
  • 16. Market trends & outlook
  • 17. Porter's five force analysis
  • 18. PESTEL analysis
  • 19. Rare cell isolation market: Products outlook key takeaways
  • 20. Rare cell isolation market: Products movement analysis
  • 21. Reagent & kits market estimates and forecasts, 2018 - 2030 (USD Million)
  • 22. Instrument market estimates and forecasts, 2018 - 2030 (USD Million)
  • 23. Rare cell isolation market: Cell type outlook key takeaways
  • 24. Rare cell isolation market: Cell type movement analysis
  • 25. Circulating tumor cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • 26. Stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • 27. Fetal cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • 28. Rare immune cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • 29. Circulating endothelial cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • 30. Other rare cell types market estimates and forecasts, 2018 - 2030 (USD Million)
  • 31. Rare cell isolation market: Technology outlook key takeaways
  • 32. Rare cell isolation market: Technology movement analysis
  • 33. Magnetic bead separation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 34. Fluorescence-activated cell sorting market estimates and forecasts, 2018 - 2030 (USD Million)
  • 35. Microfluidics-based techniques market estimates and forecasts, 2018 - 2030 (USD Million)
  • 36. Regional marketplace outlook, 2023 & 2030 (USD Million)
  • 37. Regional marketplace: Key takeaways
  • 38. North America rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 39. Key country dynamics
  • 40. U.S. rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 41. Key country dynamics
  • 42. Canada rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 43. Key country dynamics
  • 44. Mexico rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 45. Europe rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 46. Key country dynamics
  • 47. UK rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 48. Key country dynamics
  • 49. Germany rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 50. Key country dynamics
  • 51. France rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 52. Key country dynamics
  • 53. Spain rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 54. Key country dynamics
  • 55. Italy rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 56. Key country dynamics
  • 57. Denmark rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 58. Key country dynamics
  • 59. Sweden rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 60. Key country dynamics
  • 61. Norway rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 62. Asia Pacific rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 63. Key country dynamics
  • 64. Japan rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 65. Key country dynamics
  • 66. China rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 67. Key country dynamics
  • 68. India rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 69. Key country dynamics
  • 70. Australia rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 71. Key country dynamics
  • 72. South Korea rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 73. Key country dynamics
  • 74. Thailand rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 75. Key country dynamics
  • 76. Market participant categorization
  • 77. Rare cell isolation market position analysis, 2023
  • 78. Strategic framework